THAP9-AS1 promotes nasopharyngeal carcinoma progression through targeted regulation of the miR-185-5p/SOX13 axis.
Jinhua MoZengyi GongHong LiuLian ZhouYanguang ZhaoPublished in: Physiology international (2024)
This work verified that THAP9-AS1 promoted NPC cell progression at least partly by mediating the miR-185-5p/SOX13 axis.